Background--The goal of this literature review was to assess sex differences in the quality of life (QoL) in patients with atrial fibrillation (AF) and, if possible, to determine if these are due to AF.
It is well known that QoL is significantly impaired in AF patients compared with the general population, 1 but less attention has been paid to the impact of sex on the QoL in this patient group. The aim of this review is to elucidate whether there is a sex difference in QoL in AF patients and, if so, if this is due to AF per se or just a reflection of sex differences in QoL in the general population.
Methods
Data are available on request, from the authors. The study included results derived from published data, and an institutional review board was not consulted.
Search Strategy
The database PubMed was searched by the Medical Subject Heading terms in 3 searches: Gender OR Female AND Atrial Fibrillation AND Quality of Life; Gender differences AND Atrial Fibrillation AND Quality of Life; and Atrial Fibrillation AND Gender AND Quality of Life.
Inclusion Criteria
Two authors (L.A.S., H.R.) screened the titles and abstracts of all the retrieved articles written in English. The full text of the articles that assessed QoL in AF patients was then screened for the presence of original data on sex differences in QoL, and any article lacking such data was excluded. When several articles examined the same study population, only the article most relevant for sex differences in QoL was included. Furthermore, articles that did not assess QoL by the most widely used generic questionnaires (Short Form-36/12 Health Survey [SF- 36/12] and/or EuroQoL [EQ-5D]) were excluded. These questionnaires are validated instruments that can be used across many diseases as well as in healthy population groups and allow comparison of populations. If other questionnaires on symptoms and mental health were used in addition to SF-36/12/EQ-5D, they were taken into account and discussed in light of the QoL findings.
Risk of Bias
Risk of bias was evaluated in studies that addressed differences in QoL between AF patients and control populations within each sex. The bias included the main classes of bias for observational cross-sectional studies: selection bias, information bias, and bias from confounding.
Results
On January 23, 2018, the search in PubMed retrieved 851 citations from the first Medical Subject Heading term search.
The subsequent 2 term searches did not give any additional citations. The full text was retrieved for 351 articles. Fifty-six citations fulfilled the inclusion criteria, and 25 articles remained for analysis after the application of exclusion criteria ( Figure) . The most widely used assessment forms are listed in Table 1 . [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Results from the different studies were summarized into separate categories: studies assessing sex differences in QoL in patients with all unspecified AF (paroxysmal, persistent, and permanent) ( Table 2) , studies assessing sex differences in QoL in patients with paroxysmal and persistent AF (Table 3) , studies assessing QoL in AF patients after intervention (Table 4) , and sex differences in mental health in patients with AF (Table 5 ). Baseline results from interventional studies were also incorporated in Tables 2  and 3 . Results from some of the studies may thus appear in several tables.
Sex Differences in QoL in Patients With Unspecified AF
Eight observational studies 4, 9, 10, 18, 21, 22, 25, 26 and the baseline assessment in 5 interventional studies 11, 15, 23, 24, 27 report sex differences in QoL in patients with all forms of AF (paroxysmal, persistent, and permanent AF) ( Table 2 ). The following assessments were used: SF-36/SF-12, 9, 10, 15, [21] [22] [23] [24] [25] [26] [27] EQ-5D, 4, 9, 11, 18, 21 AFEQT (Atrial Fibrillation Effect on Qualityof-Life), 18, 27 University of Toronto Atrial Fibrillation Severity Scale, 15, 22 Atrial Fibrillation Symptom Checklist, 22 and Multidimensional Fatigue Inventory-20. 15 Evaluation of the clinical impact of between-group differences in scores was suggested as a minimal important difference (MID) of 2, 0.07, and 7 units for Physical Summary Score (PCS) or Mental Component Summary Score (MCS), EQ-5D Index, and EQ-5D Visual Analogue Scale, respectively, 21 a 10% difference in PCS or MCS, 22 or a difference in mean SF-36 subscale score of 1 standard deviation. 15 Six studies reported significantly lower QoL in female compared with male AF patients, 4, 9, 11, 22, 23, 25, 26 and 3 studies reported numerically lower QoL in female compared with male patients, lower than MID for PCS and MCS or 1 standard deviation for SF-36 subscales, 10, 15, 21 whereas 2 studies demonstrated no statistically significant sex difference in QoL. 18, 24 Three studies revealed that female AF patients reported more symptoms than male AF patients. 4, 15, 22 Four studies compared results from AF patients with either a control population or with values from a reference population 10, 11, 21, 23 : Roalfe et al and Hoegh et al compared AF male and female patients with men and women in a general population. Both found that female and male AF patients reported clinically significant lower PCS and small and comparable differences in MCS compared with a female and male general population. 10, 21 Furthermore, in the study by
Clinical Perspective
What Is New?
• Female patients with atrial fibrillation (AF) have poorer quality of life than male patients with AF.
• Few studies, however, compare AF patients with non-AF subjects from the same source population.
What Are the Clinical Implications?
• It is not yet established whether the sex difference in quality of life in AF is greater than it is in the general non-AF population.
Roalfe et al, the AF patients aged 75+ who reported mild total disability (Rankin score <2) had better physical QoL than the general population. 21 One study showed lower QoL scores in women with AF compared with men but did not find a corresponding sex difference in a control population with venous thromboembolism.
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Sex Differences in QoL in Patients With Paroxysmal and Persistent AF QoL was assessed in 3 observational studies 20, 28, 36 and at baseline in 7 interventional studies [29] [30] [31] [32] [33] [34] [35] in patients with paroxysmal or persistent AF ( Three studies revealed no statistically significant sex difference in QoL. 28, 35, 36 Four studies compared results from their AF population with either a healthy control group or values from a reference population. [29] [30] [31] 35 Substudies of the Rate Control Versus Electrical Cardioversion and the Canadian Trial of Atrial Fibrillation showed that female AF patients had worse QoL than women in a reference population, predominantly on physical health. 30, 31 In the Canadian Trial of Atrial Fibrillation, both male and female AF patients had worse QoL than an age-matched reference population; still, female patients had a relatively greater impairment than their age-matched reference population, and than male patients had compared with their reference population. 31 In a study of surgical AF ablation patients, both men and women with AF had lower PCS scores than a sex-and age-stratified reference population. 29 Finally, 4 studies demonstrated that female patients with AF report more symptoms than male AF patients 20, [29] [30] [31] despite no worse AF burden.
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Records identified through PubMed search (n = 851)
Records screened for AF and QoL in abstract and/or title (n = 351)
Records excluded (n=295) -Did not assess sex differences in QoL in AF patients
Full-text papers assessed for eligibility (n = 56)
Studies included in qualitative synthesis (n = 25)
Full-text articles excluded (n=31) -did not use SF-36 or EQ-5D -no original data on sex differences in QoL
Figure. 
Sex Differences in QoL in Patients After Interventions
Ten studies examined QoL in AF patients after various interventions (Table 4) . Four studies evaluated the effect of rate or rhythm control, 15, 27, 30, 31 4 the effect of ablation, 24, 29, 34, 35 and 2 evaluated other interventions in AF patients 11, 33 (Table 4) .
Sex Differences in QoL After Rate or Rhythm Control in AF Patients
One randomized controlled trial assessed the effect of rate versus rhythm-control on QoL in AF patients: no difference was revealed. Female patients did, however, have worse QoL and higher cardiovascular mortality and morbidity in the rhythm-control EQ-5D Index and VAS: EuroQoL 5D
EQ-5D is a generic questionnaire that consists of 2 parts; EQ-5D Index and EQ-5D Visual Analogue Scale (VAS). EQ-5D Index assesses QoL in 5 dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). Each dimension has 3 levels of severity: no problems, some/moderate problems, or extreme problems. The EQ-5D questionnaire gives 243 (3 5 ) possible health states. These states are converted into a single summary index by adding preference weights from population norms. The EQ-5D Index ranges from 0 to 1, with a higher score indicating higher QoL, EQ VAS measures the individuals' perceived health from 0 (worst imaginable health state) to 100 (best imaginable health state). Results before intervention † : Female sex had lower SF-36 subscale scores on PF, RP, BP, SF, and VT and higher symptom score (AFSS). Age adjustment not specified. Sex was associated with high MFI-20 scores (above the mean value +1 SD) on the scales for physical fatigue and reduced active adjustment not explicitly specified.
group. 30 Two studies assessed the effect of rhythm control on QoL: 1 randomized controlled trial compared 3 different antiarrhythmic drug treatments, 31 and 1 study assessed electrical cardioversion. 27 The randomized controlled trial on antiarrhythmic drugs demonstrated an improvement in QoL in both sexes after intervention; although the improvement on PCS was significant only for female patients, the improvement in and MCS was significant only for male patients. 31 The same study also revealed an improvement in symptom frequency and severity in both sexes, but women remained significantly worse. One study assessed rate-control treatment in AF patients. This substudy of Rate Control Versus Electrical Cardioversion II demonstrated no significant effect on QoL in either the lenient or the strict control group, but female sex was associated with lower QoL at all time points. 15 
Sex Differences in QoL After AF Ablation
All 4 studies demonstrated an improvement in QoL after ablation of AF, 24, 29, 34, 35 with comparable improvements for female and male patients. 24, 34, 35 Interestingly, after the surgical ablation procedure in 1 study, AF patients surpassed their age-and sex-norm data on QoL scores: female patients only on PCS and male patients only on MCS. In addition, even though there was a similar improvement in AF symptom frequency, female patients reported greater overall symptom frequency than male patients at all time points. Results after ablation, but before rehabilitation † : Female patients had lower scores on PCS but not on MCS or HADS scores compared with male patients, and non-significantly lower scores for AFEQT symptoms, daily activity, and global scores. Age adjusted.
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Sex Differences in QoL After Other Interventions in AF Patients
One study assessed the effect of anticoagulant therapy in AF patients compared with venous thromboembolic patients: in both groups both sexes improved after treatment, but in the AF group female patients had lower EQ-5D scores compared with male patients. This sex difference was not seen in the venous thromboembolic group. 11 The second study assessed the effect of comprehensive rehabilitation versus usual care after catheter ablation. There were improvements in QoL and physical outcome in female patients only, and mental outcomes in male patients only, compared with the groups receiving usual care. No significant sex difference in SF-36 was found in either group. 33 
Sex Differences in Mental Health in Patients With AF
The following assessments were used in the 2 studies: SF- (Table 5 ). Both studies demonstrated that female patients had poorer PCS but similar MCS compared with male patients, 19, 37 and for women the PCS was nearly clinically significant as poorer than for normative data, whereas male patients were comparable to normative data. 37 One study revealed that female AF patients reported higher levels of depressive symptoms relative to male patients. 37 
Risk of Bias
Nine studies included some form of sex-stratified comparison of QoL in AF patients versus a normal or control population in strata by sex (Table 6 ). Systematic evaluation of risk of bias proposed an overall intermediate or high risk of bias in all but 1 study.
10,21
Discussion
The present overall review demonstrates that female AF patients report poorer QoL,* and are more symptomatic than male AF patients. 4, 15, 19, 20, 22, [29] [30] [31] 37 Interestingly, the majority of the studies reveal that female AF patients scored lower, predominantly on the physical component score of the SF-36, 10, 19, 20, 31, 33, 37 although only a few female patients had significantly lower scores on the mental component score.
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Only 4 studies showed neither a significant sex difference nor a tendency toward women scoring lower in QoL. 18, 28, 35, 36 Female AF patients were also more likely to present with No sex difference in proportion that regained sinus rhythm. Female AF patients' PCS and MCS scores were lower than those of male patients, and overall symptom frequency and severity scores were higher at all points of time. Both PCS and MCS improved in both sexes, surpassing age and sex group norms for PCS (female) and MCS (male). Overall AF symptom frequency and severity declined similarly in both sexes. PCS: Both male and female patients improved significantly between baseline and 6 mo. Female patients improved significantly from baseline to 12 mo and surpassed their age and sex group norms (by 3.6 points, P=0.003), whereas male patients were similar to their age and sex norms (AF 1.6 points higher than norm, P=0.09).
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anxiety and/or depression. 37 Compared with the general population, both men and women with AF had poorer QoL scores, 31 especially for the physical component of QoL.
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Could Poorer QoL in Women in General Explain the Sex Differences in AF?
The most widely used self-reporting questionnaires are SF-36 and EQ-5D/Visual Analogue Scale. These generic questionnaires reflect the individuals' general aspect of physical, mental, and social functioning, which is strongly influenced by other factors such as comorbidity and age. Several studies illustrate that women in the general population report lower QoL than men and that female sex and increasing age are independently associated with reduced QoL. [38] [39] [40] [41] [42] [43] [44] In addition to reduced QoL, it seems that older respondents in the AF population, 36 as well as in the general population, 40, 41, 43 largely score lower on physical
QoL. This is consistent with recent normative data from the EQ-5D assessed at baseline and at 3-mo follow-up.
Female AF patients had lower score than males on EQ-5D, both at baseline and follow-up. QoL improved after 3 mo on anticoagulant treatment, although less in AF than in VTE. EQ-VAS improved in both sexes, but for EQ-Index score, significantly only in men. No significant difference was seen between female and male patients in the VTE group. QoL data not age adjusted. Comprehensive rehabilitation after ablation was better than usual care in women (AFEQT global and treatment concern scores), but in men only HADS-anxiety was better. For SF-36, no significant group difference was found from baseline to follow-up, despite PCS and MCS improved numerically by >2 units for both intervention groups in both sexes. Data are age adjusted.
Values followed by AE indicate meanAESD. SF-36 summary scores are physical summary score (PCS) and mental component summary score (MCS). AF indicates atrial fibrillation; AFEQT, Atrial Fibrillation Effect on Quality of Life; AF-SCL, Symptom Checklist-Frequency and Severity Scale; AFSS, University of Toronto Atrial Fibrillation Severity Scale; DC, direct current; EQ-5D, generic questionnaire that consists of 2 parts; EQ-5D Index and EQ-5D Visual Analogue Scale (VAS); HADS, The Hospital Anxiety and Depression Scale; OR, odds ratio; QoL, quality of life; RCT, randomized controlled trial; VTE, venous thromboembolism; SF-36, Medical Outcomes Study Short-Form 36 Health Survey.
general Norwegian population. 45 It can therefore be hypothesized that increasing age, more comorbidity, and female sex are associated with reduced QoL, especially with physical health, and that our findings are only a reflection of the sex differences in the general population. Women in the general population also report more physical symptoms. 46, 47 Even though female AF patients experience more severe AF-related symptoms, there does not seem to be a sex effect on AF frequency and duration. 20, 30, 31 Thus, women may be more sensitive to AF episodes or have a lower threshold for reporting illness burden, and we may therefore speculate if this sex difference in QoL is not due to AF per se but rather to women's perception of illness and style of responding.
The literature reports more anxiety and depression among women in the general population 48 as well as in cardiovascular conditions, 49, 50 and it is well known that depression and anxiety are related to poorer QoL. 37 However, it is possible that the sex difference in anxiety and depression prevalence depends on the diagnostic methods used, and use of a symptom scale may yield higher scores in female than in male patients. 48 Because various assessment methods are used to measure anxiety and depression, it is difficult to know whether female AF patients are more prone to depression/anxiety or if women merely are more sensitive to symptoms. Female AF patients might be more worried by their AF episodes, and fear of their next episode might affect anxiety and depression scores.
Could AF Per Se Be Responsible for Lower QoL in Female AF Patients?
Only a few studies support the inference that female AF patients might have lower QoL than males due to AF per se. Paquette et al demonstrated a relatively greater impairment in QoL in female AF patients compared with their agematched controls than was the case for men with AF, most notably on the physical components. Still, the relative sex difference was <0.5 standard deviation unit and lower than the suggested MID of 1 standard deviation unit. 31 Similarly, the Rate Control Versus Electrical Cardioversion and Canadian Trial of Atrial Fibrillation studies showed that female AF patients had worse QoL than women in the general population, predominantly on physical health. 30 , 31 Marvig et al found that female AF patients had significantly lower scores on EQ-Index and Visual Analogue Scale compared with male AF patients, although this sex difference was not significant in the control population with venous thromboembolism. 11 In the study by Hoegh et al the difference in PCS between AF patients and a non-AF general population was worse in women than in men. Still, the relative sex difference was <1 score point, and hence it was lower than the MID for AF indicates atrial fibrillation; QoL, quality of life; MID, minimal important difference; RCT, randomized controlled trial.
PCS of 2 score points. 10 Also, in the study by Roalfe et al the between-sex difference in QoL relative to normative data was 1.9 MCS score units poorer in women and below the MID. 21 These results both support the fact that AF has a relatively greater impact on physical QoL in women than in men but that this reduction in QoL may be too small to have clinical relevance. The interventional studies included in this review (Table 4) show an improvement in QoL in both sexes, independent of the type of intervention. Henry et al found that female AF patients who underwent Cox-maze surgery for AF had a relatively greater improvement in PCS and even surpassed their age and sex norms, whereas male AF patients improved to the norm level. 29 Paquette et al revealed a similar trend, with female AF patients improving more in PCS than did male patients. However, there is no clear trend suggesting more improvement after intervention in female compared with male AF patients.
It is important to note that only 1 of the studies included in this review compared sex differences in their AF population with sex differences in non-AF patients recruited in the same way from the same source population 10 (Table 5) . A few studies compared their AF population with a control group 10, 11, 30 to normative values from a database 21, 23, 29, 31, 35, 37 or to reference values from other publications, 9, 22, 27 and selection bias may be present because inclusion into these studies may differ from that of the comparator population. This comparison is important to clarify if the sex difference seen in QoL in AF patients is due to the disease per se, but such clarification may be difficult, particularly in interventional studies. The major limitation of this review is that very few authors have focused on sex differences in QoL in AF compared with sex differences in QoL in a control group. Even though some studies used normative data or a control group, their data are not always age or sex adjusted. As shown in Table 6 , even the most relevant studies had an intermediate to high risk of bias. Only 1 study provided the optimal design: to select reference participants from the same source population as the AF patients. 10 In addition, the majority of the studies did not distinguish among the various forms of AF and used different inclusion criteria. Samples from different AF populations were also used, mainly from either primary-care or from tertiary-care units. This makes it difficult to generalize the results because the majority of the patients referred to tertiary clinics have a greater sickness burden than the average AF patient. It is also noteworthy that age adjustment for QoL often is not clearly described. Women with AF are generally older with more comorbidity, and age adjustment is therefore essential. Despite equal numbers of male and female AF patients, men tend to be overrepresented in the clinical studies. The limitations listed above make it hard to draw a conclusion as to whether female AF patients fare worse than male patients compared with the sex differences in the general population.
In conclusion, the present review demonstrates that women consistently report lower QoL, both in AF and in the general population. So far, the evidence slightly supports the hypothesis that women's QoL is more affected by AF than is the case in men. At present, however, it is questionable whether the relatively poorer QoL in women is large enough to be of clinical importance.
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